MomentumIQ Navigation
Strategy Library
All Strategies Stock Screener
Learn & Research
Learning Center Calculators
Sign In Sign Up Free

Upgrade to Pro

Unlimited backtests · All signals · ₹399/month

Upgrade Now →

CIPLA — Cipla

Download Report (XLSX)
Quick Nav CIPLA Overview ← Screener
CIPLA · NSE
Cipla
Pharmaceuticals NSE Equity Data: 11 Sep 2026
₹1,366.00
₹7.28 (-0.53%)
52W High₹1,525.40
52W Low₹1,154.89
Avg Vol (20D)7.82L
RSI 1435.2
Vol Ratio2.15×
ATR 14₹21.88
5D Change-1.37%
📊 Analysis: CIPLA closed at ₹1,366.00 today, down 0.53%. RSI at 35.2 — below midpoint, momentum is weak. Price is 2.4% below its 200-day EMA (₹1,399.52) — long-term trend is down. Volume was 2.15× the average — above-normal interest from market participants. Average daily range (ATR14) is ₹21.88 (1.6% of price) — useful for setting stop loss levels.
Price History — 365 trading days
Daily · NSE

Technical Conditions — 11 Sep 2026

Volume > 2× Avg
2.15× average volume — unusual activity
Below EMA200
Price below 200-day EMA — long-term downtrend

Technical Indicators

Momentum
RSI (14)
35.2
Neutral
MACD
-17.9176
Signal: -12.6601
MACD Histogram
-5.2576
Bearish momentum
1D Change
-0.53%
5D Change
-1.37%
Volume Ratio
2.15×
Above average
Trend — EMA Levels
EMA 20
₹1,403.80
↓ Price below
EMA 50
₹1,414.47
↓ Price below
EMA 200
₹1,399.52
↓ Long-term downtrend
vs EMA 50
-3.43%
vs EMA 200
-2.4%
EMA Alignment
Mixed
Volatility — Bollinger Bands
BB Upper
₹1,456.37
BB Mid (SMA20)
₹1,408.35
BB Lower
₹1,360.33
BB Width
0.0682
Normal width
ATR (14)
₹21.88
Daily range average
ATR % of Price
1.6%
Stop loss guide
Price Levels
52W High
₹1,525.40
At 52W high
52W Low
₹1,154.89
+18.28% above
From 52W High
-10.45%
NR7
No
Narrow range 7-day
NR4
No
Narrow range 4-day
Price > 20D High
No

30-Day Indicator History

Date Close RSI 1D % Vol × Conditions
11 Sep ₹1,366.00 35.2 -0.53% 2.2× VOL
10 Sep ₹1,373.30 36.9 +0.75% 1.1×
09 Sep ₹1,363.10 32.8 -1.51% 1.1×
08 Sep ₹1,384.00 37.5 -0.79%
07 Sep ₹1,395.00 40.3 +0.72% 0.8×
04 Sep ₹1,385.00 36.2 -0.7% 1.8×
03 Sep ₹1,394.70 38.6 -1.28% 0.8×
02 Sep ₹1,412.80 43.4 -0.72% 0.8×
01 Sep ₹1,423.00 46.5 +0.98% 1.2×
31 Aug ₹1,409.20 41.3 -1% 1.3×
28 Aug ₹1,423.50 45.6 +0.25% 0.5×
27 Aug ₹1,420.00 44.3 +1.23% 0.7×
26 Aug ₹1,402.70 37.3 -1.36% 1.1×
25 Aug ₹1,422.00 42.8 -1.11% 0.9×
24 Aug ₹1,437.90 48.3 +0.4% 1.3×
21 Aug ₹1,432.20 46 -0.4% 0.8×
20 Aug ₹1,438.00 48 +1.13% 0.3×
19 Aug ₹1,422.00 41.5 -0.64% 0.4×
18 Aug ₹1,431.10 44.4 -0.03% 0.5×
17 Aug ₹1,431.50 44.6 -1.28% 0.6×
14 Aug ₹1,450.00 50.9 -0.6% 0.6×
13 Aug ₹1,458.80 54.4 -0.29% 0.3×
12 Aug ₹1,463.00 56.1 +0% 0.5×
11 Aug ₹1,463.00 56.1 -0.32% 0.7×
10 Aug ₹1,467.70 57.8 +0.27% 0.5×
07 Aug ₹1,463.80 56.8 -0.89% 0.6×
06 Aug ₹1,477.00 61.5 +1.25% 1.1×
05 Aug ₹1,458.80 56.9 -0.08% 0.7×
04 Aug ₹1,460.00 57.3 -0.98% 0.7×
03 Aug ₹1,474.40 62.4 +0.08% 0.6×

Sector Peers — Pharmaceuticals

Symbol Price 1D % RSI Vol × EMA50
DRREDDY
Dr. Reddys Laboratories
₹1,165.50 +1.97% 47.7 ↓ Below View →
ALKEM
Alkem Laboratories
₹5,087.50 -0.98% 28.8 ↓ Below View →
PFIZER
Pfizer
₹4,060.20 -0.86% 18.5 1.8× ↓ Below View →
BIOCON
Biocon
₹390.65 -0.26% 31.9 1.3× ↓ Below View →
ABBOTINDIA
Abbott India
₹25,550.00 +1.15% 36.3 1.3× ↓ Below View →
DIVISLAB
Divi's Laboratories
₹9,322.00 -1.23% 63.7 1.2× ↑ Above View →
SUNPHARMA
Sun Pharmaceutical
₹1,840.00 -1.13% 34 ↓ Below View →
TORNTPHARM
Torrent Pharmaceuticals
₹4,965.50 +0.72% 52.2 0.9× ↑ Above View →

Want to backtest a strategy on CIPLA?

Choose from 443 pre-built NSE strategies and see historical results in 60 seconds.

Sign Up Free →
Run Free Backtest Now

We use cookies to keep you signed in and understand how the platform is used. See our Privacy Policy.

Still there?

Here's something you might like

or

One email a week. No spam, unsubscribe anytime.

SEBI Compliance Disclaimer

MomentumIQ is an educational platform for strategy research and backtesting. We do not provide investment advice, recommendations, or tips. All backtest results are hypothetical, based on historical data, and for educational purposes only. Past performance is not indicative of future results. Backtested results may not account for brokerage, slippage, taxes, or other real-world costs. Please consult a SEBI-registered investment advisor before making any investment decisions.